SFU Library Licensed Material

Access to the content in this collection is restricted to current SFU faculty, students, and staff.

This collection contains various types of content licensed by the SFU Library on behalf of the University. 

Copyright and Terms of use

This work is protected by copyright in Canada unless its copyright has expired. The user is responsible for doing their own assessment. 

You may use this work as permitted by applicable licenses, fair dealing and other exceptions under copyright legislation in your jurisdiction. For guidance on seeking further permissions, contact the source/owner of the material.

Search within Collection

Displaying 76 - 90 of 710

Delivering Opportunities in the Inhalable Drugs Market,Datamonitor report

BI00019-001-Thumbnail Image.png
Date: 2010-02-22
Name(s): Norman, Peter
Description: The delivery of drugs using inhaled formulations is currently heavily underexploited except. It represents an opportunity to provide an effective delivery route for therapeutics, such as proteins, that are suitable for this delivery route.

Delivery Mechanisms for Large Molecule Drugs,Datamonitor report

BI00019-005-Thumbnail Image.png
Date: 2009-01-09
Name(s): Fraser-Moodie, Isabel
Description: For currently marketed products, reformulations with new delivery technologies will extend the period of patent protection. New formulas will also boost sales of large molecule products in diseases where patient compliance is a limitation on growth.

Design, manufacture and use of intermediate bulk containers for the transportation of dangerous goods, classes 3, 4, 5, 6.1, 8 and 9

sfulibr_1218-Thumbnail Image.png
Date: 2016-04-26

Developments in Neurostimulation,Datamonitor report

BI00043-009-Thumbnail Image.png
Date: 2011-06-23
Description: Neurostimulation is currently undergoing extensive research in segments that include deep brain stimulation (DBS), microstumulation, and spinal cord stimulation. Business Insights assesses the impact of these innovations.

Digital Content in Public Libraries Report

sfulibr_357-Thumbnail Image.png
Date: 2015

Discover QGIS 3.X : a workbook for classroom or independent study

ebook-Thumbnail Image.png
Date: 2022
Name(s): Menke, Kurt

Disruptive Technology in the Enterprise,Datamonitor report

BI00029-036-Thumbnail Image.png
Date: 2009-10-20
Name(s): Eastwood, Gary
Description: Ignoring technological innovation and development can leave organizations, and indeed entire industries, vulnerable to disruption from new technologies. This report explains what disruption is, what causes it, and how organizations can avoid it.

Distributed Generation Markets in Europe,Datamonitor report

BI00018-017-Thumbnail Image.png
Date: 2010-03-09
Name(s): Clark, Martin
Description: European efforts to combat climate change, improve security of supply, drive innovation, and boost competitiveness over the next decade will cause the distributed generation (DG) share of Europe's electricity generation capacity to grow considerably.

DNA Sequencing In Drug Discovery,Datamonitor report

BI00020-025-Thumbnail Image.png
Date: 2010-01-04
Name(s): Merchant, Mahi
Description: DNA sequencing technology has had a vast impact on the field of drug discovery and the success of the Human Genome Project. Developments in microarrays, bioinformatics and similar tools have increased the scope of applications and services.

Drapeau national du Canada (pour utilisation à l'intérieur)

sfulibr_1429-Thumbnail Image.png
Date: 2018-08

Driving Brand Loyalty in Food and Drinks,Datamonitor report

BI00014-023-Thumbnail Image.png
Date: 2009-11-25
Name(s): Bartlett, Ron
Description: The recession has driven a substantial change in consumer behavior and attitudes. This has driven the widespread debate about the extent to which consumers will return to their pre-recession shopping and spending behavior.

Drug Approval Trends at the FDA and EMEA,Datamonitor report

BI00027-012-Thumbnail Image.png
Date: 2008-03-04
Name(s): Sahoo, Alison
Description: Drug approvals in the US and Europe have become subject to approval delays, rising requests for further clinical data, and greater chances of rejection. Regulators are currently attempting to reconfigure review processes in order to minimize delays.

Drug Delivery Innovations Driving Improved Patient Compliance,Datamonitor report

BI00039-004-Thumbnail Image.png
Date: 2011-07-22
Name(s): Thomalla, Lise
Description: Patient noncompliance with therapy regimens is often thought to be the single greatest threat to successful treatment in chronic conditions. Many companies are developing technologies to overcome the drivers of noncompliance.

Drug Delivery Partnership Strategies,Datamonitor report

BI00019-008-Thumbnail Image.png
Date: 2012-03-05
Name(s): Seget, Steven
Description: Innovative drug delivery technologies are playing an increasingly important role in extending lifecycles, differentiating me-too products and unlocking the value of new compounds with challenging delivery requirements.

Drug Development Opportunities in China,Datamonitor report

BI00020-008-Thumbnail Image.png
Date: 2007-09-20
Name(s): Sahoo, Alison
Description: China has emerged as an increasingly attractive option for companies aiming to reduce prohibitive investments in time and finance during drug development.